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Abstract. Expression of the ß-galactoside a2,6-
sialyltransferase (a2,6-ST) was shown to regulate the
generation of multiple cell-surface differentiation anti-
gens (Ags) that may be necessary for lymphocyte
function. A new mAb was produced, termed HB-6,
that was shown to identify a novel neuraminidase-
sensitive cell-surface Ag expressed by subpopulations
of human lymphocytes and erythrocytes. In attempting
to isolate a cDNA encoding the HB-6 antigen by ex-
pression cloning, a cDNA encoding the a2,6-ST (EC
2 .4.99.1) was obtained. Since expression of the a2,6-
ST protein was shown to be limited to the Golgi ap-
paratus, the cell-surface HB-6 Ag was demonstrated to
be the product of c12,6-ST activity. Interestingly, a2,6-
T
HE identification of leukocyte cell-surface structures,
delineation of their primary amino acid sequences,
and elucidation of their potential functions has been a
major focus in the field of immunology during the last de-
cade. Each cell-surface protein has been found to have a
unique primary sequence that presumably directs function of
the molecule. However, these proteins may also serve as
scaffolds for the presentation of cell-surface carbohydrates.
It is likely that cell-surface carbohydrates are also functional
moieties with a broad potential for diversity not only in
the proteins upon which they may appear, but also in the
complexityofcarbohydrate side chains possible (46, 49, 51) .
In this study, we have examined some of the potential diver-
sity in three leukocyte cell surface antigens (Ag)', HB-6,
CDw75, and CD76.
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ST expression also generated two other neuraminidase-
sensitive lymphocyte cell-surface differentiation Ags,
CDw75, and CD76. The HB-6, CDw75, and CD76
mAb identified distinct Ags that were differentially ex-
pressed by different B cell lines and exhibited different
patterns of expression in tissue sections. These results
indicate that a2,6-ST expression is a critical regula-
tory step in the formation of the Ags that are recog-
nized by these mAb, and that an a2,6-linked sialic
acid residue is an essential component of each Ag.
Thus, expression of a single ST can result in the
generation of multiple distinct antigenic determinants
on the cell surface which can be distinguished by mAb
and may have regulatory roles in lymphocyte function.
The CDw75 Ag is a cell surface molecule expressed by the
majority of blood B cells and a subpopulation of blood T
cells (9) . Four mAb were used to define CDw75 (see Table
I): EBU-141 (9), LNI (12), OKB-4 (39), and HH2 (55).
LN-1 also reacts with red blood cell precursors (12). These
CDw75 mAb are likely to identify spatially related structures
since binding inhibition studies have shown that binding of
each CDw75 mAb blocks the binding of the other CDw75
mAb (40). Several studies indicate that CDw75 is expressed
only on mature sIg+ B-cells, with expression occurring
laterthan sIg and ceasing during terminal differentiation into
plasma cells (reviewed in 9). The CDw75 mAb also react
weakly with about30% ofperipheral blood T cells. A unique
feature of CDw75 is its predominant expression by germinal
center B cells(9, 12, 29, 42), with weaker expression by fol-
licle mantle-zone B cells (9). The OKB-4 n Ab immuno-
precipitated a surface Ag of 53,000 M (40) in one study,
but of 87,000 M in another (39), while other CDw75 mAb
fail to precipitate defined structures. However, a cDNA as-
peripheral blood mononuclearcells by sheep erythrocyte rosette formation;
E- PBMC, nonadherent mononuclear cells that do not rosette with sheep
erythrocytes.
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sociated with CDw75 expression was recently cloned by
Stamenkovic et al. (56), who suggested that CDw75 is a cell
surface ß-galactoside c12,6-sialyltransferase (a2,6-ST) .
The CD76 Ag is identified by two mAbs, HD-66 and
CRIS-4, which react strongly with mature B cells and
moderately with mature T lymphocytes (8, 36, 41). Within
the B cell lineage, CD76 is not expressed on early B-cells,
but is expressed on the majority of sIgM+ B cells (8).
Within the T cell lineage, the CD76 Ag is predominantly ex-
pressed on mature cells (8, 36). In contrast to the CDw75
mAb, the CD76 mAb show a different characteristic staining
pattern in lymphoid tissues, being reactive exclusively with
mantle-zone B-cells within secondary follicles (8) . The same
(or spatially related) epitope on the CD76 molecule is de-
tected by both mAbs (40) . While the HD66 mAb im-
munoprecipitates protein bands of 85,000 and 67,000 M,
(8), most recently, the two CD76 mAb have been shown to
identify a carbohydrate Ag present on gangliosides (27) .
However, the two CD76 mAb may actually have different
ligand specificities, with the CRIS-4 mAb identifying many
gangliosides of higher polarity than the HD66 mAb (27) .
This is consistent with the observation that whilesimilar, the
HD66 and CRIS-4 mAb differ in their reactivities. The
CRIS-4 mAb stains a portion of granulocytes, the myeloid
cell line HL-60, and the T cell line CEM, while the HD66
mAb does not stain these cells at detectable levels (8) .
The HB-6 mAb reacts with a heretofore uncharacterized
surface molecule which is unique in that it is one of the few
lymphocyte cell surface molecules expressed by "spotted"
cells, which are thought to represent the precursor for multi-
ple myeloma plasma cells (34). In this study, the cellular ex-
pression of the HB-6 Ag was examined, revealing similari-
ties with the CDw75 and CD76 Ag. In addition, cDNAs that
generate the HB-6 Ag were isolated, revealing that a sialyl-
transferase is responsible for HB-6 Ag production. More-
over, expression of this sialyltransferase in COS cells was
sufficient to generate cell surface expression of the CDw75
and CD76 differentiation Ag.
Materials andMethods
Antibodies
The HB-6 mAb described in this report was produced in the laboratory of
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Dr. Max D. Cooper (University of Alabama, Birmingham, AL). Hybrid-
omasweregenerated by fusionof spleen cells (from female Balb/c mice im-
munized with the BJAB lymphoblastoid cell line) with P3X63Ag8.653 my-
eloma cells as described (26). The HB-6 mAb was of the IgM isotype as
determined by indirect inununofluorescence staining with mouse Ig isotype
specific reagents (Southern Biotechnology Associates, Birmingham, AL).
Optimal indirect immuofluorescence staining was obtained by using a 11500
dilution ofHB-6 ascites fluid. The HB-6 mAb was also conjugated to FIX
and used at a concentration of 5 pg/ml. Other mAbs used include the
CDW75 mAb, EBU-141 (9), LNl (12), OKB-4 (39), and HH2 (55), and the
CD76 mAb HD66 and CHRIS-4 (8), all of the IgM isotype and obtained
from the Fourth International Workshop on Human Leukocyte Differentia-
tion Antigens. The HB-10(CD45RA, IgM) mAb was as described (61), the
CD20 mAb HB-13a (AP-291; IgM) was as described (59), CD24 was
identified using the HB-9 mAb (60), CD57 using the HNK-1 mAb (1), CD15
using the MMA mAb (22), CD2 using the Anti-TI l to mAb (IgM) (38),
CDw60 using the anti-UM4D4 mAb (24), and B7 was identified using an
anti-B7 mAb (IgM) (16). CD3, CD4, and CD8 were identified using the
Leu-4, Leu-3, and Leu-2 mAb, respectively (Becton-Dickinson, Sunny-
vale, CA).
The polyclonal rabbit antibody specific for the a2,6-ST was produced by
immunization with purified rat liver a2,6-ST as described (68) and was
affinity purified using recombinant protein as an immunosorbent.
CellSamples
Mononuclear cells were isolated from blood and tissues by Ficoll-Hypaque
density gradient centrifugation ofheparinized single cell suspensions. Cells
were obtained by protocols approved by the Human Protection Committee
ofDana-Farber Cancer Institute and the University ofAlabama inBirming-
ham. Cells were kept at 4°C and examined immediately after isolation.
Monocytes wereisolated from PBMC by plastic adherence (adherentcells).
T lymphocytes (E+ PBMC) were isolated from the nonadherent mononu-
clear cell population by rosette formation with sheep erythrocytes treated
with 2-aminoethylisothiouronium bromide and subsequentdensity gradient
centrifugation (44). The remaining fraction ofcells (E- PBMC) contained
60-80% B cells that expressed the surface Ag, CD19, or CD20. Neutrophils
were isolated from blood samples at 20°C by centrifugation for 20 min at
1,000 g ona cushion ofMono-Poly Resolving Medium (Flow Laboratories,
McLean, VA) followed by lysis of the red blood cells with ice-cold hypo-
tonic 0.2% (wt/vol) NaCl solution.
All human lymphoblastoidcell lines weregrown in RPMI 1640 medium
containing 10% FCS and antibiotics. Malignant leukocytes were examined
as freshly isolated cell samples where >90% of the cells were determined
to be tumor cells by morphological and cell surface marker analysis. Cases
were considered positive if >20% ofthe cells were reactive with the HB-6
mAb by indirect immunofluorescence with flow cytometry analysis.
Immunofluorescence Analysis
Indirect immunofluorescence analysis was carried out after washing the
cells three times. Suspensions ofviable cells were analyzed for surface Ag
expression by incubation for 20 min on ice with the appropriate mAb as
ascites fluid dilutedto the optimal concentration for immunostaining. After
washing, the cells were treated for 20 min at 4°C with TRITC- or FITC-
conjugated goat anti-mouse Ig antibodies (Southern Biotechnology Associ-
ates). Singlecolorimmunofluorescence analysis was performed onan Epics
Profile flow cytometer (Coulter Electronics, Hialeah, FL) or a FACS IV
(Becton-Dickinson, Mountain View, CA). 10,000 cells were analyzed in
each instance and all histograms are shown on a three decade log scale.
Fluorescence staining was also visualized using a Leitz Orthoplan fluores-
cence microscope equippedwith Ploem epi-illumination and discriminating
sets ofexcitation and barrier filters. For two-color indirect immunofluores-
cence analysis, the cells were stained with mouse mAb and counterstained
with TRITC- or FITC-conjugated goat anti-mouse Ig heavy chain-specific
antibodies (Southern Biotechnology Associates) .
CharacterizationoftheHB-6Ag
To assess cell surface HB-6 Ag sensitivity to enzyme treatment, cells (5 x
106/ml) were washed in PBS and incubated in normal saline (pH 7.4) con-
taining trypsin (2.5 mg/ml) or Vibrio cholerae neuraminidase (Calbiochem,
LaJolla, CA; 0.1 U/ml) for30 min at 37°C. Similar procedureswere carried
out for CD45RA as a control using the HB-10 mAb (61) . After treatment,
the cell preparations were washed with RPMI 1640 medium containing
15% FCS and were stained for indirect immunofluorescence analysis.
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Antigen mAb Isotype Reference
Unknown HB-6 IgM 60
CDw75 EBU-141 IgM 9
CDw75 LN1 IgM 12
CDw75 OKB-4 IgM 39
CDw75 HH2 IgM 55
CD76 HD-66 IgM 8
CD76 CRIS-4 IgM 8
CD2 anti-T1111) IgM 38
CD15 MMA IgM 22
CD20 HB-13a IgM 59
CD24 HB-9 IgM 60
CD45RA HB-10 IgM 61
CD57 HNK-1 IgM 1
CDw60 anti-UM4D4 IgM 24
B7 anti-B7 IgM 16cDNA Isolation
Human spleen cells were activated as described (17) and their RNA was iso-
lated by a modification of the guanidine thiocyanate/CsCl gradient centri-
fugation technique (54). Poly(A)+ RNA was purified by two cycles of
oligo(dT) selection and used to generate cDNA that was inserted into the
pCDM8 vector (52) for library construction. Plasmid DNA was isolated
from a 500-ml culture of the original transformation of the spleen cDNA
library and purified by the alkaline lysis procedure followed by banding in
CsClequilibriumgradients twice (35). In furtherprocedures, DNAwas iso-
lated using Qiagen pack-500 columns (Qiagen, Studio City, CA) according
to the manufacturer's instructions.
In the first round of library screening, sixteen 100 mm dishes of 50%
confluent COS cells were transfected with 50 ng of plasmid per ml using
the DEAE-dextran method (53). The cells were trypsinizedand replated af-
ter 24 h ofculture. After48 h, the cells were detached by incubation in PBS
(pH 7.4) with 0.5 mM EDTA and 0.02% Na azide at 37°C for 30 min. The
detached cells were incubated with the HB-6 mAb, washed and distributed
into panning dishes coated with affinity purified goat anti-mouse IgM anti-
body (Southern Biotechnology Associates), and allowed to attach at room
temperature. After 3 h, the plates were gently washed thrice with PBS con-
taining0.5 mM EDTA, 0.02% Na azide, and 5% FCS, and once with 0.01 M
Hepes buffer (pH7.4) containing 150 mM NaCl. Episomal DNA wasrecov-
ered from the panned cells and transformed into E. coli Mc1061/p3 using
high-efficiency electroporation as described (10). Plasmids isolated from
these cells were used forthe second round ofpanning with identical proce-
dures. In the third round of panning, plasmid DNA was introduced into
COS cells by spheroplast fusion as described (53).
The plasmid DNA isolated after immunoselection contained a high fre-
quency of plasmids with deleted segments. To identify the intact plasmids,
the transformed E. coli generated after the third round ofimmunoselection
were plated sparsely (about400 colonies per 82-mm dish) and a nitrocellu-
lose replicate lift was prepared. The filter was hybridized with a 32P-
labeled oligonucleotide, GCTAACTAGAGAACCCACTG, thatcorresponds
to nucleotides 2131-2150 ofthe pCDM8 vector. This region is located 86
by5'ofthecDNA insertion site. Colonies which gavepositive hybridization
in Southern blot analysis were likely to contain intact plasmids containing
cDNAs and these were transferred into microtiter plates containing media
and grownovernight. Bacteria from multiple wells were pooledandplasmid
DNA isolated. These DNAs were then used to transfect COS cells to iden-
tify plasmids which encoded HB-6 by invnunofluorescence analysis with
subsequent identification of the single wells which contained the appropri-
ate plasmid.
The pHB-6 cDNAinsert was subcloned intothe plasmidpSP65 (37). Re-
striction maps were generated as described by Maniatis et al. (35) and
nucleotide sequences were determined using the method of Sanger (50). A
computer search of nucleotide and protein sequences was conducted using
the Protein Identification Resource Data (Swiss-Prot-15). Gap penalties of
-1 were assessed during sequence homology analysis for each nucleotide
or amino acid in the sequence where a gap or deletion occurred.
FluorescentStainingofcDNA TransfectedCOS Cells
For cell surface HB-6, CDW75, and CD76 Ag analysis, COS cells were
transfected with CD2 (53), B7 (17), CD19 (58), CD20 (62), and HB-6
cDNAs cloned into pCDM8. After overnight culture, the cells were re-
moved from the plates by treatment with trypsin, plated onto glass micro-
scope coverslips, and incubated for an additional 24 h before staining with
mAb. For intracellular Ag staining experiments, 1 x 105 COS-1 cells were
plated on glass coverslips and grown to 5075% confluence. Coverslips
were washed twice with Opti-MEM (Gibco-BRL, Gaithersburg, MD) con-
taining 55 AM 0-mercaptoethanol (Opti-MEM I medium) before transfec-
tion. COS cells were transfected with cDNA encoding the rat a2,6-ST (68)
subcloned into the pSVL expression vector (Pharmacia Fine Chemicals,
Piscataway, NJ). Transfections wereperformed as described (15) using 1 ug
ofplasmid DNA added to 125 Al ofOpti-MEM I medium. This was mixed
with 125 AI ofLipofectin reagent (Gibco-BRL) and added to a washed cov-
erslip. After incubation for 5-6 h at 37°C in a 5% CO2 incubator, 250 A1
of fresh medium containing 10% FBS was added to the coverslips which
were then incubated for 40-48 h.
cDNAtransfected COS cells were washed with PBS- (Dulbecco's PBS
withoutCA' and Mg" salts; Irving Scientific, Santa Ana, CA) and fixed
in 1% paraformaldelyde for 5 min. After two washes in PBS the cells were
permeabilized with 0.1 % Triton X-100 for 5 min. Thepermeabilization step
was omitted when only cell surface staining was desired. Fixed cells were
incubated for45 min in blocking buffer (0.5% goat serum, 0.02 % Na azide
in PBS-) at room temperature. Blocking buffer was removed and 250 AI of
Bast et al. HB-6, CDw75, and CD76 Generated by a2,6,-Sialyltransferase
a combination ofa 1:100 dilution of affinity-purified rabbit antirat a2,6-ST
antibody and a 1:250 dilution of HB-6 ascites fluid in blocking buffer was
added to each coverslip and incubation was continued for 45 min at room
temperature. Cells were washed four times for 5 min with 500 Al PBS- at
room temperature. A combination ofa 1:100dilution of TRIM-conjugated
goat anti-rabbit IgG (Boehringer Mannheim Biochemicals, Indianapolis,
IN) and a 1:100 dilution ofFrW-conjugated F(ab)2 goat anti-mouse IgM
(Jackson ImmunoResearch Laboratories, West Grove, PA) in blocking
buffer was added and the incubation allowed to continue for 45 min. Cells
were again washed four times for 5 min each with 500 Al PBS- and
mounted on microscope slides. Cells were visualized and pictures taken
using a Nikon Microphot-FXA fluorescence microscope.
RNA andDNA BlotAnalysis
Poly(A)+ RNA was isolated as described (54). For Northern blot analysis,
-5 jig of poly(A)+ RNA was denatured with formaldehyde, fractionated
by electrophoresis through a 1.2% agarose gel and transferred to nitrocellu-
lose (63). The cDNA inserts used as probes were isolated, twice gel
purified, nick-translated (48), and hybridized with the filters as described
(66). Hybridization was with 50% (vol/vol) formamide, 4x SSC, 0.1 M
NaPO4, PH 7.0, 1% Denhardt's, 50 pg/ml single-stranded salmon DNA
and 10% (wt/vol) Na dextran sulfate at 42°C. The filters were washed at
65°C with 0.2x SSC, 0.1% SDS. RNA size was determined by comparison
with denatured HindIII-digested X DNA fragments run on the same gels as
standards. RNA fromblood T cells was from pooled samplesof RNA from
cellsactivated for30 min to24 h or36-72 h with PMAandphytohemagglu-
tinin as described (3). RNA from spleen B lymphocytes was from pooled
samples of RNA from cells stimulated with anti-Ig antibodies for 30 min
to 72 h as described (3).
DNA blot hybridization using Nitroplus membranes (MSI, Inc., West-
borough, MA) was as described (14, 35) .
Immunohistochemistry
Blocks ofhyperplastic tonsils from four individuals were snap-frozenin liq-
uid nitrogen and cryostat sections cut. These were immunohistochemically
stained using an avidin-biotin-peroxidase technique with the chromagen di-
aminobenzidine as described (47).
Results
Production andCharacterization oftheHB-6 mAb
The HB6 mAb-producing hybridoma was generated with
spleen cells obtained from mice immunized with the human
B lymphoblastoid cell line, WAR The reactivityofthe HB-6
mAb with subpopulations ofblood cells was assessed by in-
direct immunofluorescence analysis (Fig. 1). Approximately
half of blood mononuclear cells (53 f 12%, n = 7) ex-
pressed the HB-6 Ag with three distinct populations of cells
observed; a negative to weakly positive population, a sub-
populationof moderately bright cells, and a small subpopu-
lation of intensely bright cells (Fig. 1). After cellular enrich-
ment for B and T lymphocytes and monocytes, the brightest
population of cells segregated with the B cells (E- PBMC),
while the moderately bright cells were mostly T cells (E+
PBMC), and monocytes (adherent cells) were negative. In
addition, CD57+ natural killer cells (73 f 15%, n = 3)
and erythrocytes were HB-6 positive and CD15+ neutro-
phils did not express detectable HB-6 Ag. Similarly, most
pre-B and B cell lines (PB-207, NALM-6, BJAB, Daudi, SB,
GK-5, Rjoy, Raji, Namalwa, Ramos, Akata, Arent), some T
cell lines (Molt-4, Rex, HPBALL), and an erythroleukernia
cell line (K562) were HB-6 positive. However, one pre-Bcell
line (PB-697), some T cell lines (Molt-3, H-SB2, Hut-78),
and a monocytic cell line (U-937) were HB-6 negative.
Two-color immunofluorescence assays were carried out to
further characterize the cells identified by the HB-6 mAb.
Essentially all blood IgM+ B cells and a large subpopula-
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Figure 1. Expression of the HB-6 Ag (solid line) examined by in-
direct immunofluorescence staining with flow cytometry analysis.
The HB-6 mAb was reactive with PBMC, the E- PBMC fraction
enriched for B cells (48% IgM+), and a T cell-enriched (E+
PBMC) fraction (96% CD3+). The mAb was unreactive with ad-
herent monocytic cells (92% CD15+). The dashed lines represent
background staining with unreactive mouse ascites fluid and the
FITC-conjugated anti-mouse Ig antibodies used as developing re-
agents.
tion of T cells were HB-6+ (Tables II and III). Among T
lymphocytes, only a smallsubpopulation ofthymocytes were
HB-6+ (Table II). Most T cells from fetal bone marrow and
newborn blood were HB-6+, while substantial numbers of
T cells from adult blood and tissues were HB-6-. Among B
cells isolated from different tissues, half of fetal liver pre-B
cells and half of B cells from fetal bone marrow and liver
were HB-6+ (Table III). In contrast, IgM+ B cells from tis-
sues containing more mature cells were essentially all HB-6+.
However, after terminal differentiation, only half of plasma
cells expressed detectable HB-6 Ag.
Expression of the HB-6 Ag by malignant leukocytes was
similar to that found in their normal counterparts. Most B
cell malignancies were HB-6+, two of four cases of pre-B
acute lymphocytic leukemia (ALL) were positive, two of
Table II. Tissue Distribution ofT Cells Expressingthe
HB-6Antigen
Cells were labeled with HB-6 mAb followed by TRTTC-conjugated antimouse
heavy chain-specific antibodies. T cell populations were identified using the
indicated mAb and FITC-conjugated antimouse y, heavy chain-specific re-
agents. Reactivity was determined by two-color indirect immunofluorescence
microscopy.
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TableIII. Tissue Distribution ofB Cells Expressing the
HB-6Antigen
HB-6 reactivity was assessed using FITC-conjugated antimouse W heavychain-
specific antibodies. B cells were identified with TRITC-conjugated antihu-
man p heavy chain-specific antibodies. Plasma cells were identified by the
presence of large amounts of cytoplasmic Ig usingTRITC-conjugated antihu-
man F(ab)z specific antibodies. Reactivity was determined by two-color in-
direct immunofluorescence microscopy.
three cases of BALL, nine ofnine cases of chronic lympho-
cytic leukemia, two oftwo cases of Hairy cell leukemia, five
of six cases of Burkitt's lymphoma, and five of six cases of
B cell lymphoma. Among malignant T cells, one of one case
of Sezary cell lymphoma and one of three cases of TALL
were HB-6 positive. One of four null cell leukemias were
HB-6 positive. None of five cases of myeloid leukemia ex-
pressed the HB-6 Ag.
Biochemical Characterization oftheHB-6"ßg
The HB-6 mAb was used to immunoprecipitate the HB-6 Ag
from surface iodinated or metabolically labeled PBMC and
B cell lines. However, no specific protein or proteins were
identified. Following trypsin treatment of PBMC a substan-
tial amount of the HB-6 Ag was still present, while the
CD45RA Ag was completely removed (Fig. 2) . In contrast,
treatment ofPBMC with neuraminidase removed essentially
all of the HB-6 Ag and had little effect on reactivity of the
HB-10 mAb. These results suggest that HB-6 mAb binding
is dependent on the presence of sialic acid residues and that
only a portion of the Ag was trypsin sensitive.
Isolation ofcDNAs That EncodetheHB-6Ag
The nature of the HB-6 Ag was further examined by expres-
sion cloning of a cDNA that generated the HB-6 epitope on
COS cells. A cDNA library was constructed in the pCDM8
vector using mRNA from activated splenic B cells. This li-
brary was introduced into COS cells, the cells were treated
with the HB-6 mAb and cells expressing the HB-6 Ag were
isolated by panning as described (53). After three rounds of
selection, the isolated plasmids were used to transform bac-
teria and the resulting colonies were analyzed for the pres-
ence of ark intact vector with a labeled oligonucleotide ho-
mologous with the region 5' of the cDNA insertion site. 6
ofthe colonies hybridized, indicating that this portion ofthe
plasmid had not been deleted in these colonies during selec-
tion and that these plasmids were likely to also contain a
cDNA insert. Positive clones were harvested and their plas-
mids were isolated and transfected into COS cells. Three
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Figure 2 . Expression of the HB-6 and HB-10 (CD45RA) Ag after
trypsin and neuraminidase treatments . Reactivity of mAb with
PBMC was examined by indirect immunofluorescence with flow
cytometry analysis.Theheavy lines indicatemAb reactivity andthe
light lines represent background staining with the FITC-conjugated
secondary antibody alone.
percentof the plasmids contained a similarcDNA insert of
3.2 kb which induced high level expression of the HB-6 Ag
in COS cells as determined by indirect immunofluorescence
analysis using the HB-6 mAb (Fig. 3) . This plasmid was
termedpHB-6. COS cells transfected withpHB-6 were reac-
tive with the HB-6 mAb, but were not reactive with other
IgM isotypemAb that identify CD24, CD2, B7, CD45RA,
CDw60, and CD20 (Fig . 3) .
That the isolated pHB-6 cDNA specifically induced ex-
pression of the HB-6 Ag and that transfection alone did not
induce HB-6 Ag expression, was further verified by trans-
fecting COS cells with pHB-6 or cDNAs encoding CD2
(53), B7 (17), CD19 (58), and CD20 (62) . Cells transfected
with each cDNA were stained with each of the murine IgM
mAb followed by indirect immunofluorescence staining and
fluorescence microscopy analysis. Only pHB-6cDNA trans-
fected COS cells reacted with the HB-6 mAb, whereas only
CD2, B7, CD19, and CD20 transfected COS cells reacted
with their respective mAb (data not shown) . Vector trans-
fected COS cells demonstrated no significant staining with
any of the mAb.
StructureandSequence of thepHB-6cDNA
A restriction map was generated for the pHB-6cDNA and
the nucleotide sequence was determined using the strategy
shown in Fig 4A. An open reading framewasidentified that
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Figure 3 . Inununofluorescent staining of pHB-6 cDNA transfected
COS cells. Transfected cells were not reactive with the control
IgM mAb HB-9 (CD24) . Similar negative results were obtained
with other IgM mAb, including TlIID (CD2), anti-B7, UM4D4
(CDw60), HB-10 (CD45RA), and HB-13a (CD20) . pHB-6-trans-
fected cells were reactive with theHB-6mAb and mAb identifying
the CDw75 (HH2, BBU-141, LNI, OKB-4) and CIY76 (HD66,
CRIS-4) Ag with 10-20% of the cells being brightly positive.
Shown are the results with the HB-6, HH2, and HD66 mAb . The
bar in the bottom left panel indicates 10 kM .
could encode a protein of406 amino acids with a single hy-
drophobic domain near the putative amino terminal end of
the protein (Fig . 4 B) . Comparison of the predicted HB-6
protein sequence withknownproteins revealed that theHB-6
Ag was homologous, if not identical to, the a2,6-ST (EC
2.4.99.1)encodedby cDNAs isolated from rat liver (68), hu-
man submaxillary gland (32), and human placental (20)
libraries . Subsequently, a human a2,6-ST cDNA has been
isolated from a humanBlymphoblastoid cell line, Daudi, li-
brary (56) . Comparison of the nucleotide sequences of the
cDNAs revealed that the pHB-6cDNA andpublishedDaudi
cDNA contained a stretch of sequence at the 5' end that is
different from that found at the 5' endofthe placentalcDNA
(underlined in Fig . 4B), suggesting that different transcrip-
tion initiation sites are used in the different cell lineages or
that differential mRNA splicing occurs . Comparison of the
nucleotide sequences between the pHB-6 cDNA and the
427
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published Daudi cDNA sequence indicated that they are
95.6% identical, while comparison of the overlapping se-
quences between the pHB-6 and placenta cDNA indicated
99.5% sequence identity (one base mismatch) . Furthermore,
comparison ofthe coding region ofthepHB-6cDNA and the
placental cDNA revealed identical nucleotide and amino
acid sequences . In contrast, thepHB-6 and Daudi nucleotide
sequences in this region were only 99.2% identical, resulting
in changes in three amino acids . Therefore, it is likely that
the pHB-6 cDNA encodes the same a2,6-ST as has previ-
ously been described (20, 32, 56, 68) .
o12,6-STmRNA Expression
Northern blot analysis was carried out with the pHB-6
cDNA insert to examine lymphocyte mRNA size and ex-
pression . «2,6-ST mRNA was expressed by every cell line
examined, but the levels of expression varied widely. Blood
T and B cells, activated or resting, and the B cell line
Namalwa expressed high levels (+++) on a relative scale,
B cell lines including Ramos, Raji, and Daudi were (++),
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Figure 4. (A) Restriction map
of the pHB-6 cDNA and the
strategy for determining nucle-
otide sequences . Maps were
constructed by standard single,
double, or triple digestions of
plasmid inserts. The putative
coding regions are speckled,
the 5' and 3' untranslated re-
gions are open, and the pre-
dicted transmembrane region
is shaded . Arrows show the
directionand extent ofnucleo-
tide sequence determination .
(B) The determined nucleo-
tide sequence and predicted
amino acid sequence of pHB-6
cDNA . The numbers shown
above the amino acid sequence
designate amino acid residue
positions of the protein and the
numbers on the right designate
nucleotide positions . Amino
acids are designated by the
single-letter code, and * indi-
cates the termination codon .
Nucleotides at the 5' end not
found in liver cDNAs are un-
derlined . The heavy line rep-
resents the putative trans-
membrane region . The start
site of previously described
human lymphocyte STcDNA
(56) is shown by a # above the
first nucleotide of overlap.
These sequence data are avail-
able from EMBL/GenBank/
DDBJ under accession num-
ber X62822 .
while the K562 erythroleukemia line, a T cell line, Rex and
chronic myelogenous leukemia, and multiple myeloma cells
expressed little (+) mRNA (Fig. 5, A and B, and data not
shown) . In addition, slight differences in the sizes ofmRNA
species were observed between different cell sources, Rex
a2,6-ST mRNA was -4.2 kb, K652 was -4.1 kb, while
mRNA from Raji or activated lymphocytes was smaller
ranging from -3.9 to -4.0 kb (Fig. 5A and data not shown) .
These minor differences in size were observed in multiple
mRNA samples and in at least three different Northern blots .
Therefore, Southern analysis was carried out to determine
whether a single gene product was being examined or
whether multiple genes were being represented . In all cases
examined, probing endonuclease digested genomic DNA
with thepHB-6 cDNA insert revealed that the x2,6-ST gene
was likely to be single copy (Fig . 5 C) as has been shown
for the rat a2,6-ST gene (57) . These results suggest that
different cell types use different transcription initiation sites
for mRNA production from a single gene or process the
mRNA differently. Nonetheless, the level ofa2,6-STmRNAFigure 5. Northern and Southern blot analysis using the pHB-6 cDNA as probe . (A) Poly(A)+ RNA isolated from cell lines, activated
blood T cells (30 min to 24 h, left ; 36 to 72 h, right) and activated spleen B cells . 5 wg of each RNA was used per lane . Autoradiography
was with an intensifying screen for 1 h . (B) The same filter as in A autoradiographed for 26 h . (C) Southern blot analysis ofDNA digested
with BamHI, EcoRI and Hind1II, electrophoresed in 0.8% agarose, transferred to nitrocellulose, and hybridized with the labeled HB-6
cDNA probe . DNA was isolated from : (lane 1) normal splenocytes ; (lane 2) the DHL-4 B cell line ; malignant leukocytes from a patient
with diffuse histiocytic lymphoma, lymph node (lane 3') and peripheral blood (lane 3) ; leukocytes from a second patient's lymph node
(lane 4') and blood (lane 4) .
expressed by different cells was consistent with the intensity
of HB-6 surface Ag expression .
Expression ofthe a2,6-ST in the Golgi
Apparatus Results in Expression oftheHB-6Agon
the Cell Surface
That lymphocytes express a2,6-ST as the cell surface
CDw75 differentiation Ag has been previously suggested
(56) . However, an overwhelming body of information indi-
cates that terminal glycosyltransferases are localized within
the Golgi apparatus (reviewed in 43) . Therefore, to deter-
mine whether expression of the a2,6-ST correlated with ex-
pression ofthe HB-6Ag on the cell surface, Cos-1 cells were
transfected with cDNA encoding the rat a2,6-ST (68) . 40-
48 h after transection, cells were fixed and lightly permeabi-
lized with 0.1% Triton X-100 to view both surface and intra-
cellular staining, or left unpermeabilized to view only cell
surface staining. Untransfected and cDNA transfected cells
were incubated with both rabbit antirat a2,6-ST antibody
and mouse anti-HB-6 mAb which were subsequently de-
tected with a TRITC-conjugated goat anti-rabbit IgG second
antibody and an FITC-conjugated goat anti-mouse IgM
F(ab)Z second antibody, respectively.
Neither the a2,6-ST nor the HB-6 Ag were detected in-
tracellularly or at the cell surface in untransfected COS-1
cells (Fig . 6) . In cDNA transfected COS-1 cells, the HB-6
Ag was detected on the surface of 10-20% of the unperme-
abilized cells, while the a2,6-ST was never detected on the
surface of these cells (Fig . 6 A) . However, in cDNA trans-
fected COS-1 cells that were permeabilized, the a2,6-ST was
localized to the perinuclear Golgi region in 10-20% of the
transfected cells and punctateHB-6Ag staining was detected
on the cell surface of only those cells expressing the ST in
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the Golgi apparatus (Fig. 6 B, third row) . In addition to cell
surface localization, the HB-6 Ag was also observed in the
Golgi apparatus of some cells, the site of its generation . In
COS cells overexpressing the ST, some ST was found in the
ER as well as Golgi (Fig. 6 B, second row), but was never
localized to the cell surface . These observations demonstrate
that expression ofthe a2,6-ST in the Golgi apparatus ofcells
correlates with the cell surface expression of the HB-6 Ag,
and indicates that the HB-6 Ag is a product of ST activity.
a2,6-ST Generates Expression of the HB-6y CDw75,
and CD76
Since CDw75 was previously suggested to be the a2,6-ST
(56) and theCD76Ag has been previously shown to include
sialic acid-bearing gangliosides (27), the reactivity of these
mAb with pHB-6 cDNA transfected COS cells was exam-
ined . In all cases, a2,6-STcDNA transfectedCOS cells were
specifically stained with each of four CDw75 mAb and both
CD76 mAb (Fig. 3) . Staining with theHB-6 and all CDw75
and C1716mAb was intense and none ofthe mAb bound un-
transfected COS cells or COS cells transfected with other
cDNAs. This finding suggests that the HB-6, CDw75, and
CD76 mAb may identify similar molecules on the cell
surface.
HB-~ CDw75, andCD76Are Distinct
Neuraminidase-sensitiveAg
Binding of the HB-6 mAb and all CDw75 and CD76 mAb
was completely eliminated by pretreatment ofPBMC or cell
lines with neuraminidase as shown for the HB-6 Ag (Fig . 2) .
Therefore, it is likely that an essential element of these four
mAb specificities is a sialic acid residue . Tlte specificity of
429Figure 6 . Expression of the HB-6Ag on the cell surface correlates with Golgi apparatus expression of thea2,6-ST. COS cells (Control)
and COS cells transfected with the rat a2,6-ST cDNA were analyzed by indirect immunofluorescence for expression and localization of
the a2,6-ST and the HB-6 Ag . Cos cells (A) fixed with 1% paraformaldehyde for detection of cell surface immunofluorescence, or (B)
permeabilized with detergent for detection of both cell surface and cytoplasmic immunofluorescence . HB-6 mAb staining was detected
using FIX-conjugated F(ab)Z goat anti-mouse IgM second antibody. The a2,6-ST was detected using an affinity-purified rabbit anti-rat
a2,6-ST polyclonal antibody and aTRTTC-conjugated goat anti-rabbitIgGsecond antibody. Thesecond panel in B showsCOS cells that
overexpress the a2,6-ST, while in the third panel normal Golgi expression is demonstrated . The bar in the bottom left panel represents
10 'M .
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430Figure 7. Binding of the
CDw75 and CD76 mAb does
notblockHB-6 mAb binding.
SB cells, which express simi-
lar levels of HB-6, CDw75,
and CD76 Ag, were stained
with FITC-labeled HB-6 mAb
after treatment with the indi-
catedmAb: Cont., control un-
reactive mouse ascites fluid;
HB-6, mAb ascites fluid di
luted1:10; CDw75, theEBU-141mAbas diluted ascites fluid(1:10) ;
CD76, the HD66 mAb as diluted ascites fluid (1:10). Reactivity of
HB-6 mAb was examined by flow cytometry. The HH2, LNI,
OKB-4, and CRIS-4 mAb also failed to block HB-6 mAb binding.
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these mAb for Ag bearing an a2,6-sialic acid determinant
was further supported by thefinding that none of these mAb
stain CHO cells which endogenously express an a-2,3-ST,
but not an a2,6-ST (33). Similarly, COS cells transfected
with a2,6-STwere notreactive with theCDw60mAb, UM-
4D4, that appears to identify a disialosyl group terminally
linked to galactose (28) . The relationship ofthe HB-6 Ag to
the CDw75 and CD76 Ag was therefore determined by ex-
amining the ability of the CDw75 and CD76 mAb to block
thebinding of labeled HB-6 mAb. Although unlabeled HB-6
mAb inhibited almost all of the binding of FITC-labeled
HB-6 mAb, none of the CDw75 or CD76 mAb significantly
affected HB-6 mAb binding (Fig. 7). Therefore, although
these mAb all share a critical componentof theirrespective
Ag, the Ags identified by the HB-6 mAb, CDw75, and CD76
mAb are distinct.
The specificities of the mAb for distinct Ag was further
demonstrated by examining the cellular distribution of the
HB-6, CDw75, and CD76 Ag. The pre-B cell line, PB-697,
expressedtheCD76 Ag only (Fig. 8). The Nalm-6 pre-Bcell
line expressed the HB-6 and CD76 Ag, but not the CDw75
Ag. The Raji cell line expressed all Ag, but the levels of
HB-6 and CDw75 Ag expression were higher than that of
CD76. In addition, the HB-6 mAbgenerated a differentpat-
tern of immunohistological staining on tonsil sections than
PB-697 NALM-6
FLUORESCENCE INTENSITY
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either theCDw75 or CIi76mAb(Fig. 9) . HB-6 mAb stained
both mantle zone and germinal center B cells, and large
numbers of lymphocytes in interfollicular (T cell) areas.
Furthermore, there was widespread expression of the HB-6
Ag by the endothelium of high endothelial venules. In con-
trast to results with the HB-6 mAb, CDw75 mAb stained
mantle zone lymphocytes relatively weakly and germinal
centers more strongly, as previously described (9, 29). The
CD76 mAb stained predominantly mantle zone B cells, as
previously described(8). Neitherthe CDw75 or CD76 mAb
were reactive with high endothelial venules. Thus, although
a2,6-sialic acid residues are critical for mAb reactivity,
additional unique components necessary for expression of
these Ag must also be required.
Discussion
The HB-6 mAb was shown to reactwith a novelcell-surface
Ag present on a subpopulation of leukocytes. The HB-6 Ag
was highly expressed by most B cells (Fig. 1, TableIII), and
at lower levels by a major subpopulation of T cells (Fig. 1,
Table 11), and was also present on erythrocytes. Among the
B and T cell lineages, the HB-6 Ag was expressed by most
lymphocytes from fetal, newborn, and adult tissues (Tables
II and 111) . Malignant counterparts of these cells were also
generally HB-6+. In contrast, while most B cell lines ex-
pressed the HB-6 Ag, many T cell lines were HB-6- or ex-
pressedonly low levels. This patternofexpression was simi-
larto that reported for theCDW75andCD76 Ags, with some
exceptions. The CDw75 and CD76 Ags are expressed late
during B cell development (9), while the HB-6 Ag was ex-
pressedduring even theearliest stages of pre-B cell develop-
ment (Table III). Also, it appearsthat the HB-6 Ag was more
broadly distributed among Tcell populations than has been
reported foreither theCDw75 or CD76 Ag (8, 9) . TheHB-6
Ag was furtherdistinguishedfrom theCDw75 andCD76 Ags
by its patterns ofexpression among cell lines (Fig. 8), distri-
bution amongcell populations within tonsil (Fig. 9), andbe-
cause the HB-6 mAb did not block the binding of either
CDw75 or CD76 mAb (Fig. 7). Therefore, the HB-6 mAb
identifies a newly characterized leukocyte cell-surface Ag.
43 1
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Figure 8. Reactivity of the
HB-6, CDw75 (HH2) and
CD76 (HD66) mAb (solid
lines) with cell lines. Reactiv-
ity of mAb was examined by
indirect immunofluorescence
with flow cytometry analysis.
Thin lines represent back-
ground staining with unreac-
tive mouse ascites fluid.
00 P
L Re'- Re'-Figure 9 . Immunohistochemistry on parallel frozen sections of hu-
man tonsil (chromogen diaminobenzidine and hematoxylin coun-
terstain) . (A) The HB-6 mAb stained mantle zone and germinal
center B cells and, unlike othermAbstudied, large numbers of ex-
trafollicular cells . (B) LNl (CDw75) mAb predominantly stained
follicularBcells. (C)CRIS-4 (CD76) mAb bound to mantle zone
B cells and scattered extrafollicular cells . Bar, 100 gM .
Isolation and sequencing of cDNA from a humanB cell
library that induced HB-6 Ag expression in COS cells re-
vealed that thesecDNA encoded a specific lymphocyte iso-
form ofhuman a2,6-ST cDNA (Fig . 4) . a2,6-ST catalyzes
the transfer of sialic acid to the terminal Ga101,4G1cNac
structures present on the oligosaccharides of glycoproteins
and glycolipids (21, 49) . cDNAs that encode a2,6-ST have
been previously cloned from rat liver and human placenta,
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submaxillary gland, and aB cell line (20, 32, 56, 68) . The
lymphocyte a2,6-ST cDNA nucleotide sequence differed
from thenonlymphoida2,6-STcDNAs in the 5'untranslated
region (Fig . 4 B), suggesting that there is differential regula-
tion ofthis gene by different cell lineages . The a2,6-ST has
previously been shown to be localizedto thetrans-cisternae
of the Golgi and trans-Golgi network (4, 43). In this study,
the proteinproduct of the c12,6-ST cDNA was shown to re-
main localized within the Golgi apparatus of cDNA trans-
fected COS cells, while the HB-6 Ag was expressed on the
cell surface (Fig . 6) . In addition, cell surface expression of
the HB-6 Ag was completely sensitive to neuraminidase
treatment and was only partially decreased after protease
treatment (Fig. 2) . These findings areconsistent with theno-
tion that the HB-6 Ag is a carbohydrate structure that is ex-
pressedon cell surface glycoproteinsandglycolipids andone
that contains an a2,6-linked sialic acid residue as a critical
component of the Ag . The isolation of acDNA which en-
codes a glycosyltransferase by the selection of transfected
cells which express theproduct of the glycosyltransferase at
the cell surface is notwithout precedent as thecDNA for sev-
eral terminal glycosyltransferases have been isolated by ex-
pression cloning (13, 30, 31) . Most recently, a cDNA encod-
ing an a-1,3-fucosyltransferase, which acts in the synthesis
of a carbohydrate moiety that constitutes the ELAM-1
ligand, was isolated by expression cloning (19) .
Another interesting finding was that expression of ce2,6-
ST not only generated the Ag identified by the HB-6 mAb,
but also the cell surface Ag identified by the CDw75 and
CD76mAb (Fig. 3) . This result suggests that the CDw75 and
CIY76 Ag are also carbohydrate determinants generated by
the expression ofthec12,6-ST. Other data concerning the na-
ture of these Ag also support this premise . First, the HB-6,
CDw75, and CI776 Ag were all highly susceptible to neur-
aminidase treatment, as was previously shown for CDw75
with theLN-1 mAb(12) . In addition, theCDw75 Ag is resis-
tant to formalin-fixation and paraffin-embedding, proce-
dures whichoften denature cell-surface proteins (9, 12, 42) .
Because all fourmAb used to defineCDw75 appear identical
in reactivity and all recognize a single epitope (40), it is
likely that they recognizeasingle carbohydrate determinant .
Second, others have shown that CI776 mAb react with
sialylated glycolipids with a NeuAca2,6Ga101,4G1cNAc0-
terminal structure (27) . Both CD76 mAb also react with
paraffin-embedded tissue sections and cross-block each
other's binding (8) . Although the reactivities of the two
characterized CD76 mAb are overlapping, they are distinct
since the HD66 and CHRIS-4mAb show major differences
in reactivities among granulocytes, the myeloid line HL-60
andthe T-cell lineCEM (8) . Thus, expression of asingle ST
is required for the generation of multiple distinct antigenic
determinants which canbe distinguished by mAb. The anti-
genic diversity ofthese cell surface determinants may reside
in their core carbohydrate structures, the synthesis and dis-
tribution of which is further controlled by the regulated
tissue- and cell type-specific expression of the appropriate
glycosyltransferases, and/or in the structures of their carrier
proteins or lipids which may also be critical for generation
of the appropriate antigen . This also indicates that the core
carbohydrate (orproteinsequence) components of theHB-6,
CDw75, and CD76 Ag are expressed by COS cells and that
all that is required for Ag expression is the addition of an
432a2,6-linked sialic acid. Therefore, the regulated expression
of different combinations of glycosyltransferases could gen-
erate considerable diversity in both protein- and lipid-bound
carbohydrate chains, further increasing the diversity and an-
tigenic nature of cell surface molecules.
Recently, Stamenkovic et al. (56) reported the cloning of
the B cell CDw75 Ag and identified it as a cell surface a2,6-
ST. However, the c0,6-ST had previously been recognized
to localize exclusively in the Golgi apparatus ofcells (4, 43).
In this study (Fig. 6) and others (Colley, K. J., E. U. Lee,
and J. C. Paulson, manuscript submitted for publication),
it was further demonstrated that when the ST was overex-
pressed in transfected COS or CHO cells, it remained local-
ized within the ER as well as the Golgi apparatus, but was
never detected on the cell surface. Additionally, the results
of this study suggest that the CDW75 Ag is a carbohydrate
structure which is generated by the a2,6-ST. So, although the
3 amino acid changes notedbetween this B cell a2,6-ST (56)
and other cloned human ST (Fig. 4, references 20, 32) could
lead to mislocalization of the enzyme to the cell surface,
it is more likely that Stamenkovic et al. (56) have cloned
the same a2,6-ST from cells expressing the cell surface,
sialylated carbohydrate Ag recognized by the CDW75 mAb.
The biological significance of expression of the HB-6,
CDw75, and CD76 Ag for lymphocyte function is unknown.
However, there are at least two possibilities. One possibility
is that expression of these cell surface carbohydrate deter-
minants may regulate interactions between cell-surface car-
bohydrates and their specific receptors. One of the best ex-
amples of this type of interaction is found within the selectin
family of endothelial-leukocyte adhesion receptors where
ligand binding is dependent on terminal sialic acid residues
(5, 25, 65) . Many other cell surface molecules with C-type
lectin domains have been identified which may also serve as
receptors for the HB-6, CDw75, and CD76 Ag (11). The sec-
ond possible function is that the sialic acid residues added
to surface carbohydrate determinants may serve as biological
masks (51, 67). Examples of this include the regulation of
homotypic interactions of N-CAM (46) .
Many immunologically important cell surface molecules
are glycosylated and many immunological recognition events
appear to be influenced by sialic acid. The ability of B cells
to induce an allogeneic response and to present Ag can be
markedly enhanced by pretreatment with sialidase (6, 18) .
Cell surface sialic acid also influences tumor cell recognition
in the mixed lymphocyte reaction presumably involving
a2,6-linked sialic acids (45) . Mitogen stimulation, cell lin-
eage commitment and differentiation, and malignant trans-
formation are all events that can dramatically alterglycosyla-
tion patterns of proteins, lipids, and glycosaminoglycans on
leukocytes (21, 23, 67) . For example, the least mature
thymocytes have the lowest levels of ST and surface sialic
acid (7, 64) . While thymocytes express little sialic acid, T
cells express more and B cells express even more (69) . Acti-
vation oflymphocytes also leads to early increases of ST ac-
tivities which precede proliferation (2) . These findings
correlate well with surface expression of the HB-6 (see Fig.
1, Tables II and III), CDw75, and CD76 Ag. However, despite
previous observations that malignant transformation of leu-
kocytes alters expression of cell-surface glycoconjugate ex-
pression (21, 67), expression of the HB-6 Ag was remark-
ably similar to that of normal leukocytes. Undoubtedly,
Bast et al. HB-6, CDw75, and CD76 Generated by a2,6,-Sialyltransferase
further advances in understanding the functional relevance
of those differences will be required before the roles of these
carbohydrate moieties will be understood.
Many of the cell surface Ags that were originally char-
acterized as CD Ag based on their selective expression by
discrete leukocyte subpopulations are now known to be car-
bohydrate moieties including : CD15 (Lewis X); CD17 (lac-
tosylceramide); CDw52; CDw60; CDw65 (ceramide-dode-
casaccharide 4c) ; CD57; and CD77 (Gb3). This study
contributes two additional members to this list, CDW75 and
CD76. That sialic acids are capable of contributing to novel
Ag should not be unexpected since they are a heterogeneous
group of at least 30 structural variants of neuraminic acid,
differing in N- and O-acetylation and other substituents.
They are predominantly linked a2,6, a2,4, or a2,3 to galac-
tose, a2,6 to Ga1Nac, a2,6 to G1cNac, and a2,8 to sialic
acid. Therefore, given the complex biochemical nature of
cell-surface glycoconjugates and the high degree of diversity
that can be achieved, it is likely that carbohydrate modifica-
tion ofcell surface structures offers an additional level of an-
tigenic specificity that will contribute to the control of lym-
phocyte interactions and function. In addition, sialic acids
are charged moieties that generally occupy terminal posi-
tions on oligosaccharides. These factors make them ideal
targets for immune recognition, as evidenced in this report.
Thus, expression of the a2,6-ST described here is likely to
play a central role in determining the expression of multiple
leukocyte cell-surface Ag.
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